Supernus Pharmaceuticals, Inc.

Sorry, but we don't have an email address for this listing

View the location of this listing

Sorry, but we don't have a phone number for this listing

Sorry, but this listing is on a subscription plan which does not allow users to schedule meetings with them

Visit Website

Pioneering Advancements in Neurology and Psychiatry for Over Three Decades.

With over three decades of expertise in the biopharmaceutical sector, this company is dedicated to the research, development, and commercialization of treatments for central nervous system disorders, including psychiatric and neurological conditions such as ADHD, epilepsy, Parkinson's disease, and migraine. The firm was initially a stand-alone development organization, later becoming a U.S. subsidiary of Shire plc before establishing its current identity in 2005. Committed to innovation, it leverages internal research and development efforts to create novel products that provide significant benefits to patient health, using its specialty sales forces to market within the United States and strategic collaborations for international reach.

The company's mission focuses on improving patients' lives by offering new solutions in neurology and psychiatry. It evaluates potential CNS product candidates with substantial commercial prospects and actively pursues strategic opportunities, such as product in-licensing, co-promotion, and co-development partnerships. Additionally, it provides various grants to medical, educational, and other organizations, reinforcing its commitment to ethical practices and solid compliance. By maintaining strong relationships with healthcare professionals and organizations, the company solidifies its leadership position and continues to inspire and reward its dedicated workforce.

Pioneering Advancements in Neurology and Psychiatry for Over Three Decades.

With over three decades of expertise in the biopharmaceutical sector, this company is dedicated to the research, development, and commercialization of treatments for central nervous system disorders, including psychiatric and neurological conditions such as ADHD, epilepsy, Parkinson's disease, and migraine. The firm was initially a stand-alone development organization, later becoming a U.S. subsidiary of Shire plc before establishing its current identity in 2005. Committed to innovation, it leverages internal research and development efforts to create novel products that provide significant benefits to patient health, using its specialty sales forces to market within the United States and strategic collaborations for international reach.

The company's mission focuses on improving patients' lives by offering new solutions in neurology and psychiatry. It evaluates potential CNS product candidates with substantial commercial prospects and actively pursues strategic opportunities, such as product in-licensing, co-promotion, and co-development partnerships. Additionally, it provides various grants to medical, educational, and other organizations, reinforcing its commitment to ethical practices and solid compliance. By maintaining strong relationships with healthcare professionals and organizations, the company solidifies its leadership position and continues to inspire and reward its dedicated workforce.

Show More

Recommendations (0)

All (0)
Recommendations (0)
Reviews (0)
Videos (0)
No data found

Locations (1)

Location Map

Headquarters

9715 Key West Ave, Rockville, MD 20850-3900, USA

Members also viewed